Related references
Note: Only part of the references are listed.Docosahexaenoic acid withstands the A beta(25-35)-induced neurotoxicity in SH-SY5Y cells
Michio Hashimoto et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for A beta(25-35)
Yury G. Kaminsky et al.
EXPERIMENTAL NEUROLOGY (2010)
Investigation of the Noncovalent Interactions Between Anti-Amyloid Agents and Amyloid β Peptides by ESI-MS
Eric Martineau et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2010)
Taurine and Brain Development: Trophic or Cytoprotective Actions?
Herminia Pasantes-Morales et al.
NEUROCHEMICAL RESEARCH (2010)
Physiological roles of taurine in heart and muscle
Stephen W. Schaffer et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Role of antioxidant activity of taurine in diabetes
Stephen W. Schaffer et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17-21 beta-amyloid sequence
Cesare Giordano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-β-peptide aggregation
Ismael Santa-Maria et al.
NEUROSCIENCE LETTERS (2007)
Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis
Bas J. H. Kuipers et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Amyloid formation via supramolecular peptide assemblies
Roger A. Moore et al.
BIOCHEMISTRY (2007)
Conformational stability of Aβ-(25-35) in the presence of thiazolidine derivatives
Pietro Campiglia et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
The α-to-β conformational transition of Alzheimer's Aβ-(1-42) peptide in aqueous media is reversible:: A step by step conformational analysis suggests the location of β conformation seeding
S Tomaselli et al.
CHEMBIOCHEM (2006)
Inhibition of protein misfolding and aggregation by small rationally-designed peptides
L. D. Estrada et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Synthesis and structural investigations of N-alkylated beta-peptidosulfonamide-peptide hybrids of the amyloidogenic amylin(20-29) sequence: implications of supramolecular folding for the design of peptide-based bionanomaterials
Ronald C. Elgersma et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2006)
Multiple assembly pathways underlie amyloid-β fibril polymorphisms
C Goldsbury et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells
Z Datki et al.
BRAIN RESEARCH BULLETIN (2003)
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease
C Adessi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
β-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease:: Implications in the pathogenesis of Alzheimer disease
T Kubo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Probing the role of backbone hydrogen bonding in β-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions
DJ Gordon et al.
BIOCHEMISTRY (2003)
Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
LY Qin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Beta-sheet breaker strategy for the treatment of Alzheimer's disease
C Adessi et al.
DRUG DEVELOPMENT RESEARCH (2002)
Multistate equilibrium unfolding of Escherichia coli dihydrofolate reductase:: Thermodynamic and spectroscopic description of the native, intermediate, and unfolded ensembles
RM Ionescu et al.
BIOCHEMISTRY (2000)
Alzheimer's amyloid fibrils: structure and assembly
LC Serpell
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Share Paper
